Clinical Trial Update: Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv)

View source ↗

Summary

This completed non-interventional study in Germany assessed patient and healthcare provider satisfaction with subcutaneous versus intravenous daratumumab as par…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Daratumumab (Darzalex) (daratumumab)
• Lenalidomide (Revlimid) (lenalidomide)

Snippet

Sponsor: iOMEDICO AG | Conditions: Multiple Myeloma, Newly Diagnosed | Status: COMPLETED